Zu, X., Ma, X., Xie, X., Lu, B., Laster, K., Liu, K., . . . Kim, D. J. (2020). 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo. J Exp Clin Cancer Res.

Zu, Xueyin, Xiaoli Ma, Xiaomeng Xie, Bingbing Lu, Kyle Laster, Kangdong Liu, Zigang Dong, and Dong Joon Kim. "2,6-DMBQ Is a Novel MTOR Inhibitor That Reduces Gastric Cancer Growth in Vitro and in Vivo." J Exp Clin Cancer Res 2020.

Zu, Xueyin, et al. "2,6-DMBQ Is a Novel MTOR Inhibitor That Reduces Gastric Cancer Growth in Vitro and in Vivo." J Exp Clin Cancer Res 2020.